Fundraising Fox

Biotech Series B Investors & VC Firms

900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.

Hitachi Ventures
MunichSeed–Series B
25 people
M Ventures
Los AngelesSeed–Growth$10.8M
9 people
Cross Creek Advisors
Salt Lake CitySeries B–Late Stage
19 people
Kyoto University Innovation Capital
KyotoPre-Seed–Growth
20 people
Primo Ventures
MilanPre-Seed–Growth$1.1M
18 people
Innovation Industries
AmsterdamSeed–Late Stage$2.2M – $54M
25 people
Kreos Capital
LondonSeries A–Late Stage
43 people
Ysios Capital
BarcelonaSeries A–Late Stage$5.4M – $21.6M
26 people
Artesian
AustraliaPre-Seed–Late Stage
42 people
Artis Ventures
San FranciscoSeed–Late Stage$50K – $25M
7 people
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
39 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Late Stage
30 people
Agent Capital
WalthamPre-Seed–Late Stage
22 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
29 people
Fortune Venture Capital
ShenzhenSeed–Late Stage$425K – $73M
11 people
UntroD Capital
TokyoPre-Seed–Growth$772K – $241M
5 people
Medicxi
LondonPre-Seed–Late Stage
34 people
S32
Palo AltoSeries A–Late Stage
25 people
Verve Ventures
ZugSeed–Series B$1.1M – $2.2M
9 people
The Column Group
San FranciscoPre-Seed–Late Stage$30M
26 people
Swanlaab Venture Factory
MadridSeed–Growth$540K – $3.2M
25 people
HealthCap
StockholmSeed–Growth
30 people
Schmidt
SeoulPre-Seed–Growth
ZhenFund
BeijingPre-Seed–Series B$425K – $28M
27 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.